Cite
Davey MG, Ryan ÉJ, Folan PJ, et al. The impact of progesterone receptor negativity on oncological outcomes in oestrogen-receptor-positive breast cancer. BJS Open. 2021;5(3)doi: 10.1093/bjsopen/zrab040.
Davey, M. G., Ryan, �. �. J., Folan, P. J., O'Halloran, N., Boland, M. R., Barry, M. K., Sweeney, K. J., Malone, C. M., McLaughlin, R. J., Kerin, M. J., & Lowery, A. J. (2021). The impact of progesterone receptor negativity on oncological outcomes in oestrogen-receptor-positive breast cancer. BJS open, 5(3), . https://doi.org/10.1093/bjsopen/zrab040
Davey, M G, et al. "The impact of progesterone receptor negativity on oncological outcomes in oestrogen-receptor-positive breast cancer." BJS open vol. 5,3 (2021). doi: https://doi.org/10.1093/bjsopen/zrab040
Davey MG, Ryan ÉJ, Folan PJ, O'Halloran N, Boland MR, Barry MK, Sweeney KJ, Malone CM, McLaughlin RJ, Kerin MJ, Lowery AJ. The impact of progesterone receptor negativity on oncological outcomes in oestrogen-receptor-positive breast cancer. BJS Open. 2021 May 07;5(3). doi: 10.1093/bjsopen/zrab040. PMID: 34013318; PMCID: PMC8134515.
Copy
Download .nbib